For any inquiries, call: +234 (01) 899 7401-2
Graphical Presentation
We anticipate sustained growth in turnover as we implement our strategy of diversion.New products launch will be sustained in the core pharmaceutical business, while new product offerings in the larger health care segments and Health/Energy drinks will expand our expand our consumer base. Please click on the link below to view our Report.
Performance Indicator
Loading ...